RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Amick, H. R., Gartlehner, G., Gaynes, B. N., & Lohr, K. N. (2016). Authors' reply to Gøtzsche and Hamilton. BMJ (Clinical research ed.), 352, i617. https://doi.org/10.1136/bmj.i617
Gøtzsche raises an important problem: the risk of dependence in people taking second generation antidepressants. The evidence for this is mixed, and the discussion of the balance between harm and benefit remains an active one.4 Careful consideration of what dependence is and how it overlaps with symptoms of drug discontinuation is key. Withdrawal symptoms are associated with discontinuation of many second generation antidepressants, but they are...